Skip to content

Medical-device intelligence

OYX: Bcr/Abl1 Monitoring Test

FDA product code OYX: Bcr/Abl1 Monitoring Test. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
OYX
FDA device name
Bcr/Abl1 Monitoring Test
Device class
2
Regulation number
866.6060
Medical specialty
Medical Genetics
Review panel
PA

FDA definition

A BCR/ABL1 Monitoring Test is a quantitative in vitro diagnostic device used to monitor the BCR/ABL1 to ABL1 ratio by reverse-transcriptase quantitative polymerase chain reaction (RQ-PCR) on whole blood or bone marrow of diagnosed Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML) patients expressing BCR-ABL1 fusion transcripts such as e13a2 and/or e14a2. It is intended for use during monitoring of treatment response by reporting results on the international scale (%IS) and as log molecular reduction (MR) value.
Explore medical genetics records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

5 clearance records and 3 recall records in the covered releases, across 6 source company names and 1 product codes. Dated history runs from Dec 22, 2017 to Jul 2, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202502
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202610
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
OYX · Bcr/Abl1 Monitoring Test53

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

8 matching records
Device / recordCompany in FDA recordSourceSource date
Fastplex™ BCR-ABL (p210) %IS digital PCR KitK252243 · OYXSuzhou Precigenome, Ltd. Co;510(k)Jul 2, 2026FDA decision date
Brand Name: Xpert BCR-ABL Ultra Model/Catalog Number: GXBCRABL-US-10Z-0959-2026 · OYXCepheidRecallDec 18, 2025FDA classification date
Brand Name: Xpert BCR-ABL Ultra Model/Catalog Number: GXBCRABL-10Z-0960-2026 · OYXCepheidRecallDec 18, 2025FDA classification date
Bio-Rad, REF: 12005660, QXDx BCR-ABL %IS KitZ-1358-2024 · OYXBio-Rad LaboratoriesRecallMar 22, 2024FDA classification date
BCR-ABL1 (p210) % IS Kit (Digital PCR Method)K221869 · OYXSuzhou Sniper Medical Technologies Co., Ltd.510(k)Sep 5, 2023FDA decision date
Xpert BCR-ABL Ultra, GeneXpert Dx System, GeneXpert Infinity-48s and GeneXpert Infinity-80 SystemsK190076 · OYXCepheid510(k)Sep 27, 2019FDA decision date
QXDx BCR-ABL %IS Kit for use on the QXDx AutoDG ddPCR SystemK181661 · OYXBio-Rad Laboratories, Inc.510(k)Feb 13, 2019FDA decision date
MRDx BCR-ABL Test, MRDx BCR-ABL Test SoftwareK173492 · OYXMolecularmd Corporation510(k)Dec 22, 2017FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗